OMA Guidelines Bundle

Obesity-Related Diseases - OMA Obesity Algorithm 2023

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349827

Contents of this Issue

Navigation

Page 4 of 23

5 TOP 10 TAKEAWAY MESSAGES: Obesity and High Blood Pressure 1. The disease of obesity may promote an increase in blood pressure and the disease of hypertension. 2. Hypertension is a major risk factor for CVD; CVD is the most common cause of mortality among patients with obesity and hypertension. 3. Patients with obesity and hypertension optimally undergo global CVD risk reduction (e.g., healthful nutrition and physical activity, smoking cessation, as well as optimal control of blood glucose, blood pressure, and blood lipids). 4. In addition to food intake contributing to positive caloric balance, dietary sodium can also increase blood pressure. Patients with obesity may have increased salt sensitivity. 5. Obesity and "fat mass disease" can contribute to sleep apnea, kidney and renal vessel compression, perivascular adipose tissue (restricting blood vessel wall expansion) and increased cardiac output — all of which can increase blood pressure. 6. Obesity promotes hyperleptinemia and hyperinsulinemia, both of which act upon the central nervous system to increase blood pressure. 7. Obesity increases the renin-angiotensin aldosterone system (RAAS) activity in the kidney resulting in increased blood pressure. 8. Obesity increases adiposopathic cytokines which increase endothelial dysfunction and increased arteriole vasoconstriction resulting in increased blood pressure. 9. Obesity decreases the natriuretic effects of heart left ventricular B-type natriuretic peptide (BNP) resulting in increased blood pressure. 10. When accompanied by weight loss, many anti-obesity agents decrease blood pressure; some anti-obesity agents may initially increase blood pressure (i.e., sympathomimetics such as phentermine) with possible longer-term reduction in blood pressure (compared to baseline) after weight loss.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases - OMA Obesity Algorithm 2023